NeuroPace (NPCE) said Friday it has priced a public offering of 6.5 million shares at $10 per share.

Gross proceeds from the offering, expected to close on Feb. 18, are expected to be $65 million, the company said.

NeuroPace said it has also granted underwriters a 30-day option to purchase up to 975,000 additional shares.

The company said it expects to use around $49.5 million of net proceeds from the offering to acquire 5.3 million shares held by KCK at $9.40 per share, and the remainder for general corporate purposes.